Important information on Gliolan (5-aminolevulinic acid, 5-ALA): What to do in case of delayed surgery and information on fluorescence in non high-grade glioma

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Gliolan
Active substance
5-aminolevulinic acid hydrochloride
Therapeutic area (MeSH)
Glioma
Procedure number
EMEA/H/C/000744/II/0018/G
Regulatory outcome
Variation
DHPC type
Type II variation
Referral name
Cyproterone-containing medicinal products
Human ATC code
L01XD04
Dissemination date
01/12/2020

How useful was this page?

Add your rating